Immunotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is characterized by extensive tumor heterogeneity at both the pathologic and molecular levels, particularly accelerated aggressiveness, and terrible metastasis. It is responsible for the increased mortality of breast cancer patients. Due to the negative expressio...
Saved in:
Main Authors: | Yifeng Cao (Author), Chuyang Chen (Author), Yi Tao (Author), Weifeng Lin (Author), Ping Wang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021) -
Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy
by: Yu Zhou, et al.
Published: (2022) -
Immunoadjuvant Nanoparticles as Trojan Horses for Enhanced Photo-Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jinxian Wu, et al.
Published: (2022) -
Light-controllable charge-reversal nanoparticles with polyinosinic-polycytidylic acid for enhancing immunotherapy of triple negative breast cancer
by: Lei Fang, et al.
Published: (2022) -
Role of flavonoids in inhibiting triple-negative breast cancer
by: Shuai Wang, et al.
Published: (2024)